March 7, 2018

Microsaic Systems PLC Q&A: FY Results for the year ended 31st December 2017 (LON:MSYS)

Microsaic Systems PLC (LON:MSYS) Chief Executive Officer Glenn Tracey caught up with DirectorsTalk for an exclusive interview to discuss their full year results for the year ended 31 December 2017..

Harvey Nash Group plc Q&A with Zeus Capital (LON:HVN)

Harvey Nash Group plc (LON:HVN) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview   Q1: Harvey Nash..

INTERVIEW: Cambria Automobiles Medium term dynamics positive – Zeus Capital

Cambria Automobiles Plc (LON:CAMB) Is the topic of discussion when Mike Allen, Head of Research at Zeus Capital talks with DirectorsTalk. Mike talks through the highlights from the pre-close trading..

Lookers PLC Executing well in tough market – Zeus Capital

Lookers PLC (LON:LOOK) has once again demonstrated good growth in challenging conditions, with clear outperformance against the market. We are maintaining our forecasts at this juncture, and have made some..

Allergy Therapeutics plc “2018 is set to be a pivotal year”

Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announced today its unaudited interim results for the six months ended 31 December 2017. Highlights (including..

Search

Funds

March 7, 2018

Search

Funds

March 7, 2018

FTSE 100

Funds